Fishman Jay A LTD Clinuvel Pharmaceuticals LTD Transaction History

Fishman Jay A LTD

  • $1.01 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 05, 2019
SELL
$16.48 - $24.7 $148,320 - $222,300
-9,000 Closed
0 $0
Q2 2019

Aug 06, 2019
BUY
$15.55 - $26.5 $139,950 - $238,500
9,000 New
9,000 $0

About Clinuvel Pharmaceuticals Ltd

CLVLY Quotes by TradingView
  • Ticker CLVLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,410,300
  • Market Cap $458M
  • Description
  • Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention...
More about CLVLY
Track This Portfolio

Track Fishman Jay A LTD Portfolio

Follow Fishman Jay A LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fishman Jay A LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email